Table 6. Prevalence of ESBL producing Salmonella.
|
Zone of Inhibition (Enhanced or Distorted) |
Head |
Body |
Tail |
ESBL Positive |
Prevalence (%) |
|
Cefotaxime, Ceftazidime |
0 |
1 |
0 |
1 |
2.56 |
|
Cefotaxime, Ceftazidime Ceftriaxone |
1 |
1 |
0 |
2 |
5.12 |
|
Total (n=39) |
1 |
2 |
0 |
3 |
7.69 |
*n=total number of isolates tested.